Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;21:660-666

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pollock, D. M.
Right arrow Articles by Opgenorth, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pollock, D. M.
Right arrow Articles by Opgenorth, T. J.

Hypertension, Vol 21, 660-666, Copyright © 1993 by American Heart Association


ARTICLES

Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition

DM Pollock, JS Polakowski, BJ Divish and TJ Opgenorth
Abbott Laboratories, Abbott Park, IL 60064.

Blockade of the renin-angiotensin system was studied in male Sprague- Dawley rats during long-term inhibition of nitric oxide synthase. Nitro- L-arginine-methyl ester (L-NAME) was placed in the drinking water for 4 weeks (approximately 100 mg/kg per day). Separate groups of rats were coadministered the angiotensin II antagonist A-81988 in the drinking water ranging from approximately 0.001 to 1 mg/kg per day. Control groups received only tap water or A-81988 alone. Each week, rats were placed in metabolic cages, and tail-cuff blood pressures and blood samples were taken. L-NAME produced a sustained elevation in tail-cuff pressure that was completely prevented by A-81988. No changes in creatinine clearance, sodium excretion, plasma creatinine concentration, or blood urea nitrogen were observed. Food and water intakes were identical in all groups. Water excretion was significantly increased in L-NAME-treated animals regardless of additional inhibitor treatment, suggesting a possible role for nitric oxide synthase in the control of water excretion; this effect was independent of blood pressure. Although less potent than A-81988, the angiotensin II antagonist losartan and the angiotensin converting enzyme inhibitor enalapril also blocked L-NAME-induced hypertension. In a separate series of experiments, rats were not given A-81988 until 2 weeks after hypertension had fully developed in L-NAME-treated rats. Within 1 week of treatment with the angiotensin II antagonist, tail-cuff pressure returned to normal. We conclude from these studies that long-term inhibition of endogenous nitric oxide production produces an angiotensin II-dependent form of hypertension.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Francois, N. Makhanova, P. Ruiz, J. Ellison, L. Mao, H. A. Rockman, and T. M. Coffman
A role for the thromboxane receptor in L-NAME hypertension
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1096 - F1102.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Vargas, J. M. Moreno, R. Wangensteen, I. Rodriguez-Gomez, and J. Garcia-Estan
The endocrine system in chronic nitric oxide deficiency
Eur. J. Endocrinol., January 1, 2007; 156(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. A Voors, P. P. van Geel, H. Buikema, M. Oosterga, D. J van Veldhuisen, and W. H van Gilst
High Angiotensin II Responsiveness is Associated with Decreased Endothelium-Dependent Relaxation in Human Arteries
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 145 - 150.
[Abstract] [PDF]


Home page
Circ. Res.Home page
G. L. Baumbach, C. D. Sigmund, and F. M. Faraci
Structure of Cerebral Arterioles in Mice Deficient in Expression of the Gene for Endothelial Nitric Oxide Synthase
Circ. Res., October 15, 2004; 95(8): 822 - 829.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. L. Graciano, R. d. C. Cavaglieri, H. Delle, W. V. Dominguez, D. E. Casarini, D. M. A. C. Malheiros, and I. L. Noronha
Intrarenal Renin-Angiotensin System Is Upregulated in Experimental Model of Progressive Renal Disease Induced by Chronic Inhibition of Nitric Oxide Synthesis
J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1805 - 1815.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. A. Fortepiani, M. C. O. Ruiz, F. Passardi, M. D. Bentley, J. Garcia-Estan, E. L. Ritman, and J. C. Romero
Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT
Am J Physiol Renal Physiol, November 1, 2003; 285(5): F852 - F860.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. F. Reckelhoff and J. C. Romero
Role of oxidative stress in angiotensin-induced hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Obst, V. Gross, J. Janke, M. Wellner, W. Schneider, and F. C. Luft
Pressure Natriuresis in AT2 Receptor-Deficient Mice with L-NAME Hypertension
J. Am. Soc. Nephrol., February 1, 2003; 14(2): 303 - 310.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Yan, D. Kim, T. Aizawa, and B. C. Berk
Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 26 - 36.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
D. Casellas, A. Herizi, A. Artuso, A. Mimran, and B. Jover
Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S84 - S90.
[Abstract] [PDF]


Home page
HypertensionHome page
L. Raij
Workshop: Hypertension and Cardiovascular Risk Factors : Role of the Angiotensin II-Nitric Oxide Interaction
Hypertension, February 1, 2001; 37(2): 767 - 773.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. C. DE GRACIA, A. OSUNA, F. O'VALLE, R. G. DEL MORAL, R. WANGENSTEEN, C. G. DEL RIO, and F. VARGAS
Deoxycorticosterone Suppresses the Effects of Losartan in Nitric Oxide--Deficient Hypertensive Rats
J. Am. Soc. Nephrol., November 1, 2000; 11(11): 1995 - 2000.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
M. KASHIWAGI, M. SHINOZAKI, H. HIRAKATA, K. TAMAKI, T. HIRANO, M. TOKUMOTO, H. GOTO, S. OKUDA, and M. FUJISHIMA
Locally Activated Renin-Angiotensin System Associated with TGF-{beta}1 as a Major Factor for Renal Injury Induced by Chronic Inhibition of Nitric Oxide Synthase in Rats
J. Am. Soc. Nephrol., April 1, 2000; 11(4): 616 - 624.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Alvarez, A. Osuna, R. Wangensteen, and F. Vargas
Interaction Between Nitric Oxide and Mineralocorticoids in the Long-Term Control of Blood Pressure
Hypertension, March 1, 2000; 35(3): 752 - 757.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Loichot, C. Cazaubon, M. Grima, W. De Jong, D. Nisato, J.-L. Imbs, and M. Barthelmebs
Vasopressin Does not Effect Hypertension Caused by Long-Term Nitric Oxide Inhibition
Hypertension, February 1, 2000; 35(2): 602 - 608.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. T. Bergamaschi, R. R. Campos, and O. U. Lopes
Rostral Ventrolateral Medulla : A Source of Sympathetic Activation in Rats Subjected to Long-Term Treatment With L-NAME
Hypertension, October 1, 1999; 34(4): 744 - 747.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. R. Riado, A. Zanesco, L. A. Barker, I. M. S. De Luca, E. Antunes, and G. De Nucci
Long-Term Nitric Oxide Inhibition and Chronotropic Responses in Rat Isolated Right Atria
Hypertension, October 1, 1999; 34(4): 802 - 807.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Rudd, M. Trolliet, S. Hope, A. W. Scribner, G. Daumerie, G. Toolan, T. Cloutier, and J. Loscalzo
Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H732 - H739.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Kalliovalkama, P. Jolma, J.-P. Tolvanen, M. Kahonen, N. Hutri-Kahonen, X. Wu, P. Holm, and I. Porsti
Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism
Cardiovasc Res, June 1, 1999; 42(3): 773 - 782.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. A. FORTEPIANI, E. RODRIGO, M. C. ORTÍZ, V. CACHOFEIRO, N. M. ATUCHA, L. M. RUILOPE, V. LAHERA, and J. GARCÍA-ESTAÑ
Pressure Natriuresis in Nitric Oxide-Deficient Hypertensive Rats: Effect of Antihypertensive Treatments
J. Am. Soc. Nephrol., January 1, 1999; 10(1): 21 - 27.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Kurtz and C. Wagner
Role of nitric oxide in the control of renin secretion
Am J Physiol Renal Physiol, December 1, 1998; 275(6): F849 - F862.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Zatz and C. Baylis
Chronic Nitric Oxide Inhibition Model Six Years On
Hypertension, December 1, 1998; 32(6): 958 - 964.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Pollock and A. Rekito
Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1998; 275(5): R1719 - R1723.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Luvara, M. E. Pueyo, M. Philippe, C. Mandet, F. Savoie, D. Henrion, and J.-B. Michel
Chronic Blockade of NO Synthase Activity Induces a Proinflammatory Phenotype in the Arterial Wall : Prevention by Angiotensin II Antagonism
Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1408 - 1416.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Usui, T. Ichiki, M. Katoh, K. Egashira, and A. Takeshita
Regulation of Angiotensin II Receptor Expression by Nitric Oxide in Rat Adrenal Gland
Hypertension, September 1, 1998; 32(3): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. D. Gonzalez, M. T. Llinas, E. Nava, L. Ghiadoni, and F. J. Salazar
Role of Nitric Oxide and Prostaglandins in the Long-term Control of Renal Function
Hypertension, July 1, 1998; 32(1): 33 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. C. Ortiz, L. A. Fortepiani, F. M. Ruiz-Marcos, N. M. Atucha, and J. Garcia-Estan
Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R760 - R766.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Qiu, D. Muchant, W. H. Beierwaltes, L. Racusen, and C. Baylis
Evolution of Chronic Nitric Oxide Inhibition Hypertension: Relationship to Renal Function
Hypertension, January 1, 1998; 31(1): 21 - 26.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Madeddu, M. V. Varoni, D. Palomba, C. Emanueli, M. P. Demontis, N. Glorioso, P. Dessi-Fulgheri, R. Sarzani, and V. Anania
Cardiovascular Phenotype of a Mouse Strain With Disruption of Bradykinin B2-Receptor Gene
Circulation, November 18, 1997; 96(10): 3570 - 3578.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. I. Madrid, M. Garcia-Salom, J. Tornel, M. De Gasparo, and F. J. Fenoy
Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1676 - R1682.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-M. Chillon, S. Ghoneim, and G. L. Baumbach
Effects of Chronic Nitric Oxide Synthase Inhibition on Cerebral Arterioles in Rats
Hypertension, November 1, 1997; 30(5): 1097 - 1104.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. I. Madrid, M. Garcia-Salom, J. Tornel, M. de Gasparo, and F. J. Fenoy
Interactions Between Nitric Oxide and Angiotensin II on Renal Cortical and Papillary Blood Flow
Hypertension, November 1, 1997; 30(5): 1175 - 1182.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Montanari, E. Tateo, E. Fasoli, D. Giberti, P. Perinotto, A. Novarini, and P. Dall'Aglio
Angiotensin II Blockade Does Not Prevent Renal Effects of L-NAME in Sodium-Repleted Humans
Hypertension, September 1, 1997; 30(3): 557 - 562.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. R. Knoblich, R. H. Freeman, and D. Villarreal
Pressure-Dependent Renin Release During Chronic Blockade of Nitric Oxide Synthase
Hypertension, November 1, 1996; 28(5): 738 - 742.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. Henrion, F. J. Dowell, B. I. Levy, and J.-B. Michel
In Vitro Alteration of Aortic Vascular Reactivity in Hypertension Induced by Chronic NG-Nitro-L-Arginine Methyl Ester
Hypertension, September 1, 1996; 28(3): 361 - 366.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. E. Ullian, D. J. Hazen-Martin, L. G. Walsh, R. K. Davda, and B. M. Egan
Carbenoxolone Damages Endothelium and Enhances Vasoconstrictor Action in Aortic Rings
Hypertension, June 1, 1996; 27(6): 1346 - 1352.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. S. Yamada, A. L. Sassaki, C. K. Fujihara, D. M. Avancini Costa Malheiros, G. De Nucci, and R. Zatz
Effect of Salt Intake and Inhibitor Dose on Arterial Hypertension and Renal Injury Induced by Chronic Nitric Oxide Blockade
Hypertension, May 1, 1996; 27(5): 1165 - 1172.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. Bouriquet, M. Dupont, A. Herizi, A. Mimran, and D. Casellas
Preglomerular Sudanophilia in L-NAME Hypertensive Rats : Involvement of Endothelin
Hypertension, March 1, 1996; 27(3): 382 - 391.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. L. Mattson and D. J. Higgins
Influence of Dietary Sodium Intake on Renal Medullary Nitric Oxide Synthase
Hypertension, March 1, 1996; 27(3): 688 - 692.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. Ono, Y. Ono, and E. D. Frohlich
ACE Inhibition Prevents and Reverses L-NAMEExacerbated Nephrosclerosis in Spontaneously Hypertensive Rats
Hypertension, February 1, 1996; 27(2): 176 - 183.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. Guan, V. Cachofeiro, M. L. Pucci, P. M. Kaminski, M. S. Wolin, and A. Nasjletti
Nitric Oxide and the Depressor Response to Angiotensin Blockade in Hypertension
Hypertension, January 1, 1996; 27(1): 19 - 24.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. Takase, P. Moreau, C. F. Kung, E. Nava, and T. F. Luscher
Antihypertensive Therapy Prevents Endothelial Dysfunction in Chronic Nitric Oxide Deficiency : Effect of Verapamil and Trandolapril
Hypertension, January 1, 1996; 27(1): 25 - 31.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Numaguchi, K. Egashira, M. Takemoto, T. Kadokami, H. Shimokawa, K. Sueishi, and A. Takeshita
Chronic Inhibition of Nitric Oxide Synthesis Causes Coronary Microvascular Remodeling in Rats
Hypertension, December 1, 1995; 26(6): 957 - 962.
[Abstract] [Full Text]


Home page
StrokeHome page
P. Moreau, H. Takase, C. F. Kung, M.-M. van Rooijen, T. Schaffner, and T. F. Luscher
Structure and Function of the Rat Basilar Artery During Chronic Nitric Oxide Synthase Inhibition
Stroke, October 1, 1995; 26(10): 1922 - 1929.
[Abstract] [Full Text]